Candel Therapeutics (CADL)

• Market cap: $313M
• 1 day: -1.05%
• 5 days: -3.75%
• 1 month: 26.12%
• 3 months: 10.78%
• 6 months: 11.66%
• Year to date: -37.15%
• 1 year: -34.91%
• 5 years: -19.29%
• 10 years: -19.29%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38